Modifying Therapy When CV Risk Factors Are Poorly Controlled
Cardiology Summary and Comment
Free
Assessing appropriate therapy modification by clinicians might be a way to measure quality of care.
By Joel M. Gore, MD
May 4, 2006
Covering:
Rodondi N et al., Ann Intern Med 2006 Apr 4; 144:475-84
Perlin JB and Pogach LM., Ann Intern Med 2006 Apr 4; 144:525-7
Anti-PTSD Effect of an Antihypertensive?
Psychiatry Summary and Comment
For some patients with PTSD, prazosin reduced emotional distress after exposure to trauma-related words.
By Steven Dubovsky, MD
May 3, 2006
Covering:
Taylor FB et al., Biol Psychiatry 2006 Apr 1; 59:577-81
ED Treatment of Severe Hypertension: Are We Following the Guidelines?
Emergency Medicine Summary and Comment
No, according to this observational study
By Richard D. Zane, MD, FAAEM
April 25, 2006
Covering:
Karras DJ et al., Ann Emerg Med 2006 Mar; 47:230-6
Pharmacotherapy for Prehypertension?
Cardiology Summary and Comment
Candesartan reduced the risk for new-onset hypertension in subjects with prehypertension, but questions remain about outcomes.
By Frederick A. Masoudi, MD, MSPH
April 20, 2006
Covering:
Julius S et al. for the Trial of Preventing Hypertension (TROPHY) Study Investigators., N Engl J Med 2006 Apr 20; 354:1685-97
Schunkert H., N Engl J Med 2006 Apr 20; 354:1742-4
Treating Prehypertension
General Medicine Summary and Comment
Trial results suggest that treating prehypertension is feasible, but many questions remain.
By Jamaluddin Moloo, MD, MPH
April 7, 2006
Covering:
Julius S et al., N Engl J Med 2006 Apr 20; 354
Schunkert H., N Engl J Med 2006 Apr 20; 354
Control Patient BP by Controlling Clinician Inertia?
Cardiology Summary and Comment
Clinician inertia might be partly responsible for inadequately controlled hypertension.
By Joel M. Gore, MD
April 6, 2006
Covering:
Okonofua EC et al., Hypertension 2006 Mar; 47:345-51
Fine LJ and Cutler JA., Hypertension 2006 Mar; 47:319-20
Cocoa Intake Associated with Lower BP and Lower Cardiovascular Mortality
Cardiology General Medicine
Data from a long-term study on cocoa consumption
By Jamaluddin Moloo, MD, MPH
April 6, 2006
Covering:
Buijsse B et al., Arch Intern Med 2006 Feb 27; 166:411-7
SSRIs and Neonatal Pulmonary Hypertension
Women's Health Summary and Comment
In this case-control study, SSRI use late in pregnancy significantly increased risk for PPHN.
By Andrew M. Kaunitz, MD
April 4, 2006
Covering:
Chambers CD et al., N Engl J Med 2006 Feb 9; 354:579-87
Cocoa Intake Associated with Lower BP and Cardiovascular Mortality
General Medicine Summary and Comment
In this long-term study, researchers found an association between cocoa intake and lower blood pressure and cardiovascular mortality.
By Jamaluddin Moloo, MD, MPH
March 14, 2006
Covering:
Buijsse B et al., Arch Intern Med 2006 Feb 27; 166:411-7
Prehypertensive BP and Risk for CHD
Cardiology General Medicine
Risk was increased significantly in subjects with systolic BP of 120–139 mm Hg or diastolic BP of 80–89 mm Hg.
By Jamaluddin Moloo, MD, MPH
March 9, 2006
Covering:
Kshirsagar AV et al., Am J Med 2006 Feb; 119:133-41
ACE Inhibitor for Advanced Renal Insufficiency
Cardiology Summary and Comment
Benazepril improved outcomes in nondiabetic patients with advanced renal insufficiency, independent of BP control.
By Harlan M. Krumholz, MD, SM
February 23, 2006
Covering:
Hou FF et al., N Engl J Med 2006 Jan 12; 354:131-40
Hebert LA., N Engl J Med 2006 Jan 12; 354:189-91
Prehypertensive BP and Risk for CHD
General Medicine Summary and Comment
Risk was increased significantly in subjects with systolic BP of 120-139 mm Hg or diastolic BP of 80-89 mm Hg.
By Jamaluddin Moloo, MD, MPH
February 21, 2006
Covering:
Kshirsagar AV et al., Am J Med 2006 Feb; 119:133-41
Obesity in Middle Age Portends Poor Outcomes in Older Age
Cardiology Summary and Comment
Insights from the Chicago Heart Association Detection Project in Industry
By JoAnne M. Foody, MD
February 16, 2006
Covering:
Yan LL et al., JAMA 2006 Jan 11; 295:190-8
Metabolic Syndrome Predicts NAFLD
Gastroenterology Summary and Comment
Prospective data suggest that the metabolic syndrome significantly increases NAFLD risk, particularly among women.
By Atif Zaman, MD, MPH
February 14, 2006
Covering:
Hamaguchi M et al., Ann Intern Med 2005 Nov 15; 143:722-8
Blood Pressure in Acute Stroke: How Low Is Too Low?
Neurology Summary and Comment
Previous research has suggested that low blood pressure is detrimental in patients with acute ischemic stroke (Neurology 2003; 61:1047 and Ann Emerg Med 2003 . . .
By Allan S. Brett, MD
February 9, 2006
Covering:
Stead LG et al., Neurology 2005 Oct 25; 65:1179-83
Renal Outcomes Data Challenge ACE Inhibitors, ARBs as First-Line Antihypertensives
Cardiology Summary and Comment
A large meta-analysis revealed little renal benefit beyond BP lowering.
By Frederick A. Masoudi, MD, MSPH
February 2, 2006
Covering:
Casas JP et al., Lancet 2005 Dec 10; 366:2026-33
ACE Inhibitors and ARBs vs. Other Antihypertensives for Renoprotection
General Medicine Summary and Comment
Free
Do different classes of antihypertensives have specific protective effects, or do all of them improve outcomes primarily by reducing blood pressure?
By Bruce Soloway, MD
January 27, 2006
Covering:
Casas JP et al., Lancet 2005 Dec 10; 366:2026-33
For Men, Dyslipidemia Now Might Mean High BP Later
Cardiology Summary and Comment
Insights from the Physicians’ Health Study
By Joel M. Gore, MD
January 26, 2006
Covering:
Halperin RO et al., Hypertension 2006 Jan; 47:45-50
Hypertension Linked to Cognitive Decline and Dementia
Psychiatry General Medicine
This review examines published reports from the last 15 years about blood pressure (BP) and the development of dementia/cognitive decline. The authors consider the effects . . .
By David A. Drachman, MD
January 25, 2006
Covering:
Qiu C et al., Lancet Neurol 2005 Aug; 4:487-99
Cola, but Not Coffee, Appears to Raise Hypertension Risk
Women's Health Summary and Comment
Free
Intake of sugared or diet caffeinated cola was associated with increased risk.
By Marian C. Limacher, MD
January 10, 2006
Covering:
Winkelmayer WC et al., JAMA 2005 Nov 9; 294:2330-5
